Articles related to SURVIVORSHIP

A retrospective analysis of more than 840,000 patients with breast cancer found lower all-cause mortality and reduced recurrence risk among those with obesity or type 2 diabetes who received GLP-1 receptor agonists compared with similar patients who did not, though the study did not establish causation.

Retrospective analysis of pediatric cancer survivors identified low overall CHIP prevalence, with antimetabolite therapy and methotrexate exposure emerging as the strongest treatment-associated signals.

The current real-world cohort study examines long-term survival outcomes in the 5 years after a COVID-19 hospitalization for adults with a solid malignancy. The study assessed the impact of vaccination status, vaccine platform, primary tumor site, and cancer treatment.

“Oncology nurses are uniquely positioned to ensure that people receive appropriate care to manage their distress. Deliberate application of the therapeutic relationship — including building rapport, validating feelings, normalizing the experience of CRD, and allowing for reflection and meaning-making — is a great way to start.” – Jennifer Stevens, PhD, RN, OCN